Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation. [PDF]
Liu J +13 more
europepmc +1 more source
Dordaviprone in H3K27M-mutant diffuse midline glioma: an editorial on emerging targeted therapy. [PDF]
Zafar S +3 more
europepmc +1 more source
Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models. [PDF]
Tomita Y +19 more
europepmc +1 more source
Peptide Vaccines for Pediatric High-Grade Glioma and Diffuse Midline Glioma: Current Progress and Future Perspectives. [PDF]
Mebrahtu AK +5 more
europepmc +1 more source
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM. [PDF]
Pfaff E +32 more
europepmc +1 more source
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline glioma. [PDF]
Vardon A +26 more
europepmc +1 more source
Diffuse midline glioma with extra central nervous system metastases in the pediatric, adolescent, and young adult population. [PDF]
Giantini-Larsen AM +10 more
europepmc +1 more source
A sensitive and specific histopathologic prognostic marker for K27M mutant pediatric glioblastomas [PDF]
core +1 more source
Diffuse midline glioma H3K27-altered with thoracic epidural metastasis: illustrative case. [PDF]
Sumita K +8 more
europepmc +1 more source

